UMCG/Accare Kinder en Jeugdpsychiatrie, 9700VB Groningen, The Netherlands.
Department of Psychiatry, University Medical Center Groningen, Groningen, The Netherlands.
J Clin Psychiatry. 2017 Jul;78(7):e790-e796. doi: 10.4088/JCP.15m10624.
The past decades have seen a surge in stimulant prescriptions for the treatment of attention-deficit/hyperactivity disorder (ADHD). Stimulants acutely alleviate symptoms and cognitive deficits associated with ADHD by modulating striatal dopamine neurotransmission and induce therapeutic changes in brain activation patterns. Long-term functional changes after treatment are unknown, as long-term studies are scarce and have focused on brain structure. In this observational study (2009-2012), we investigated associations between lifetime stimulant treatment history and neural activity during reward processing.
Participants fulfilling DSM-5 criteria for ADHD (N = 269) were classified according to stimulant treatment trajectory. Of those, 124 performed a monetary incentive delay task during magnetic resonance imaging, all in their nonmedicated state (nEARLY&INTENSE = 51; nLATE&MODERATE = 49; nEARLY&MODERATE = 9; nNAIVE = 15; mean age = 17.4 years; range, 10-26 years). Whole-brain analyses were performed with additional focus on the striatum, concentrating on the 2 largest treatment groups.
Compared to the late-and-moderate treatment group, the early-and-intense treatment group showed more activation in the supplementary motor area and dorsal anterior cingulate cortex (SMA/dACC) during reward outcome (cluster size = 8,696 mm³; PCLUSTER < .001). SMA/dACC activation of the control group fell in between the 2 treatment groups. Treatment history was not associated with striatal activation during reward processing.
Our findings are compatible with previous reports of acute increases of SMA/dACC activity in individuals with ADHD after stimulant administration. Higher SMA/dACC activity may indicate that patients with a history of intensive stimulant treatment, but currently off medication, recruit brain regions for cognitive control and/or decision-making upon being rewarded. No striatal or structural changes were found.
过去几十年中,用于治疗注意力缺陷多动障碍(ADHD)的兴奋剂处方数量激增。兴奋剂通过调节纹状体多巴胺神经传递,急性缓解与 ADHD 相关的症状和认知缺陷,并诱导大脑激活模式的治疗性变化。由于长期研究稀缺且集中于大脑结构,因此尚不清楚治疗后的长期功能变化。在这项观察性研究(2009-2012 年)中,我们研究了一生中兴奋剂治疗史与奖励处理过程中的神经活动之间的关联。
根据兴奋剂治疗轨迹对符合 DSM-5 ADHD 标准的参与者(N=269)进行分类。其中,124 名参与者在磁共振成像期间执行了货币奖励延迟任务,所有人均处于未用药状态(nEARLY&INTENSE=51;nLATE&MODERATE=49;nEARLY&MODERATE=9;nNAIVE=15;平均年龄=17.4 岁;范围,10-26 岁)。进行了全脑分析,并特别关注了最大的 2 个治疗组的纹状体。
与晚-中度治疗组相比,早-强度治疗组在奖励结果期间表现出补充运动区和背侧前扣带皮层(SMA/dACC)的更多激活(簇大小=8696mm³;PCLUSTER<.001)。对照组的 SMA/dACC 激活介于这两个治疗组之间。治疗史与奖励处理过程中的纹状体激活无关。
我们的研究结果与先前报道的 ADHD 患者在兴奋剂给药后 SMA/dACC 活动急性增加的报道一致。更高的 SMA/dACC 活性可能表明,有过密集兴奋剂治疗史但目前停药的患者在获得奖励时会募集大脑区域来进行认知控制和/或决策。未发现纹状体或结构变化。